Safety and Immunogenicity Study of Thiomersal-free Hepatitis E Vaccine in People Ages 16 Years and Above
Clinical trial NCT06564116 · COMPLETED
Trial details
- NCT number
- NCT06564116
- Sponsor
- Xiamen Innovax Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-22
- Primary completion
- 2024-03-28
- Enrollment
- 612
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.